Business Context and Reporting Period
Company: Inogen, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: January 7, 2019
Reporting Period: The filing announces upcoming investor conference presentations and provides an update on inside sales representative headcount as of December 31, 2018.
Key Financial Metrics
This filing does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The only quantitative metric disclosed is:
- Inside Sales Representative Headcount: 446 (as of December 31, 2018).
Material Changes
The filing discloses an update to the inside sales representative headcount included in the company's investor presentation. No other material changes to financial position or operations are reported in this document.
Guidance, Outlook, and Management Commentary
Upcoming Events: Company officers are scheduled to present at the following conferences:
- 2019 J.P. Morgan Healthcare Conference: Wednesday, January 9, 2019, at 3:30 PM PT in San Francisco.
- 21st Annual Needham Growth Conference: Wednesday, January 16, 2019, at 2:10 PM ET in New York City.
Materials: An updated slide presentation (Exhibit 99.1) containing the headcount update and additional oxygen therapy market information is attached. Live audio webcasts will be available on the company's Investor Relations website.
Legal Disclaimer: The information furnished, including the presentation, is not deemed "filed" under the Exchange Act and is not subject to the liabilities of Section 18, nor is it incorporated by reference into other filings except as expressly set forth.
Investor Verification Checklist
- Verify the updated inside sales headcount of 446 against the attached Exhibit 99.1 presentation.
- Access the live audio webcasts or recordings of the January 9 and January 16, 2019, conference presentations for management commentary.
- Review the attached Exhibit 99.1 for specific details on the oxygen therapy market mentioned in the filing.
- Note that this 8-K does not contain audited financial results; refer to the most recent 10-K or 10-Q for financial metrics.